These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12679734)

  • 1. The effect of Taurolidine on adherent and floating subpopulations of melanoma cells.
    Shrayer DP; Lukoff H; King T; Calabresi P
    Anticancer Drugs; 2003 Apr; 14(4):295-303. PubMed ID: 12679734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.
    Calabresi P; Goulette FA; Darnowski JW
    Cancer Res; 2001 Sep; 61(18):6816-21. PubMed ID: 11559556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
    Nici L; Monfils B; Calabresi P
    Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
    Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
    J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
    Da Costa ML; Redmond HP; Bouchier-Hayes DJ
    J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.
    Rodak R; Kubota H; Ishihara H; Eugster HP; Könü D; Möhler H; Yonekawa Y; Frei K
    J Neurosurg; 2005 Jun; 102(6):1055-68. PubMed ID: 16028765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of taurolidine on brain tumor cells.
    Stendel R; Stoltenburg-Didinger G; Al Keikh CL; Wattrodt M; Brock M
    Anticancer Res; 2002; 22(2A):809-14. PubMed ID: 12014655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.
    Stendel R; Scheurer L; Stoltenburg-Didinger G; Brock M; Möhler H
    Anticancer Res; 2003; 23(3B):2309-14. PubMed ID: 12894508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taurolidine specifically inhibits growth of neuroblastoma cell lines in vitro.
    Luckert C; Eschenburg G; Roth B; Appl B; Reinshagen K; Bergholz R
    J Pediatr Hematol Oncol; 2014 May; 36(4):e219-23. PubMed ID: 24762556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Taurolidine: a novel anti-neoplastic agent induces apoptosis of osteosarcoma cell lines.
    Walters DK; Muff R; Langsam B; Gruber P; Born W; Fuchs B
    Invest New Drugs; 2007 Aug; 25(4):305-12. PubMed ID: 17458504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taurolidine: preclinical evaluation of a novel, highly selective, agent for bone marrow purging.
    Ribizzi I; Darnowski JW; Goulette FA; Akhtar MS; Chatterjee D; Calabresi P
    Bone Marrow Transplant; 2002 Feb; 29(4):313-9. PubMed ID: 11896428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro effect of taurolidine on squamous cell carcinoma in the oral cavity].
    Petrovic L; Schlegel KA; Ries J; Park J; Diebel E; Schultze-Mosgau S; Wiltfang J
    Mund Kiefer Gesichtschir; 2003 Mar; 7(2):102-7. PubMed ID: 12664255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic and antineoplastic evaluation of taurolidine in the DU145 model of human prostate cancer.
    Darnowski JW; Goulette FA; Cousens LP; Chatterjee D; Calabresi P
    Cancer Chemother Pharmacol; 2004 Sep; 54(3):249-58. PubMed ID: 15173956
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Byer B; Schlein LJ; Rose B; Séguin B
    Can J Vet Res; 2020 Apr; 84(2):115-123. PubMed ID: 32255906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual functionality of the antimicrobial agent taurolidine which demonstrates effective anti-tumor properties in pediatric neuroblastoma.
    Swift L; Zhang C; Kovalchuk O; Boklan J; Trippett T; Narendran A
    Invest New Drugs; 2020 Jun; 38(3):690-699. PubMed ID: 31264069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressive reagent taurolidine inhibits growth of malignant melanoma--a mouse model.
    Braumann C; Jacobi CA; Rogalla S; Menenakos C; Fuehrer K; Trefzer U; Hofmann M
    J Surg Res; 2007 Dec; 143(2):372-8. PubMed ID: 17612567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taurolidine inhibits tumor cell growth in vitro and in vivo.
    McCourt M; Wang JH; Sookhai S; Redmond HP
    Ann Surg Oncol; 2000 Oct; 7(9):685-91. PubMed ID: 11034247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taurolidine Sensitivity of Eryptosis, the Suicidal Erythrocyte Death.
    Fink M; Al Mamun Bhuyan A; Zacharopoulou N; Lang F
    Cell Physiol Biochem; 2018; 51(2):501-512. PubMed ID: 30458445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis.
    Braumann C; Henke W; Jacobi CA; Dubiel W
    Int J Cancer; 2004 Nov; 112(2):225-30. PubMed ID: 15352034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of taurolidine on the growth of CC531 coloncarcinoma cells in vitro and in a laparoscopic animal model in rats.
    Nestler G; Schulz HU; Schubert D; Krüger S; Lippert H; Pross M
    Surg Endosc; 2005 Feb; 19(2):280-4. PubMed ID: 15870965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.